Pharmosa Biopharm Inc. (TPEX:6875)

Taiwan · Delayed Price · Currency is TWD

48.50

+0.60 (1.25%)

May 14, 2025, 1:30 PM CST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
New Drug Development	167.57M	Log In
New Drug Development Growth	-46.72%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	167.49M	Log In
United States Growth	-46.74%	Log In
Taiwan	75.00K	Log In